http://www.fpnotebook.com/
ButenafineAka: Mentax
- See Also
- Mechanism
- Naphthalenemethylamine derivative (similar to Terbinafine)
- Indications
- Refractory cutaneous Tinea Infections (e.g. Tinea Pedis, Tinea Cruris)
- Dosing
- Apply once daily for 14 days to a 2 cm area surrounding Skin Infection
- Note: Unlike other Topical Antifungals, once daily application is sufficient
- Advantages
- Shorter course (2 instead of 4 weeks) than Clotrimazole
- More convenient (once daily) than other Topical Antifungals
- Disadvantages
- Expensive
- Efficacy
- High tinea cure rates with a 2 week course
- At 4-8 weeks, no significant difference in cure as compared with Clotrimazole
- References
butenafine (C0107497) | |
|---|---|
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | C067594 |
| English | butenafine, BUTENAFINE PREPARATION |
| Spanish | butenafina |
| Parent Concepts | Benzylamines (C0005106), Naphthalenes (C0027378), [DE102] ANTIFUNGAL, TOPICAL (C0973520), Antifungal Agents (C0003308), Naphthalenemethylamine derivative (C1689973), Dermatological Antifungals (C1579274) |
| Sources | MSH, NDFRT, RXNORM, SCTSPA, SNOMEDCT, USPMG, VANDF Derived from the NIH UMLS (Unified Medical Language System) |
Mentax (C0721666) | |
|---|---|
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | C067594 |
| English | Bertek brand of butenafine hydrochloride, Mentax |
| Sources | MSH, NCI, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |